<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02101632</url>
  </required_header>
  <id_info>
    <org_study_id>2012/07/B/ST6/01238</org_study_id>
    <nct_id>NCT02101632</nct_id>
  </id_info>
  <brief_title>Myorelaxant Effect of Bee Venom(BV) Topical Skin Application in Patients With RDC/TMD Ia and Ib</brief_title>
  <acronym>BV/TMD</acronym>
  <official_title>Myorelaxant Effect of Bee Venom(BV) Topical Skin Application in Patients With Research Diagnostic Criteria/Temporomandibular Disorder Ia and Ib (RDC/TMD) Randomized, Double Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Silesia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Silesia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Topical application of BV ointment in patients with Research Diagnostic
      Criteria/Temporomandibular Disorder 1a and 1b (RDC/TMD) in experimental group, compared to
      placebo (vaseline) in control group.Application was repeated 3 times a day, during 14 days.
      Surface electromyography (EMG) was used to measure masseter rest tonus and maximal voluntary
      contraction tonus. Pain intensity was also analysed in VAS scale. Effectiveness of BV was
      compared with placebo in masseter myofascial pain in patients with TMD
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study was evaluation of myorelaxant action of bee venom(BV) ointment,
      comparing to placebo.Parallel group, randomized double blinded trial was performed, including
      79 patients with painful RDC/TMD 1a and 1b. Muscle tension was measured twice (TON1 and TON2)
      in rest muscle tonus (RMT) and maximal muscle contraction (MMC) on both sides right and left,
      with Easy Train Myo EMG (Version 3.1). Pain intensity was also analysed in VAS scale
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2014</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Masseter muscle tension</measure>
    <time_frame>2 weeks</time_frame>
    <description>Masseter muscle tension at rest and in maximal voluntary contraction, electromyographic measurement [V]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity of masseter muscle</measure>
    <time_frame>2 weeks</time_frame>
    <description>Pain intensity evaluation after 2 weeks of physiotherapy in visual analoque scale (VAS) scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">79</enrollment>
  <condition>Other Disorders of Muscle in Diseases Classified Elsewhere</condition>
  <arm_group>
    <arm_group_label>Bee Venom</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bee Venom Ointment 0,0005%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaseline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Vaseline ointment</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Bee Venom Ointment</intervention_name>
    <description>2 weeks</description>
    <arm_group_label>Bee Venom</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vaseline Ointment</intervention_name>
    <description>2 weeks</description>
    <arm_group_label>Vaseline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  RDC/TMD 1a and 1b

          -  agreement to participate in the experimental study

        Exclusion Criteria:

          -  bee venom allergy

          -  hyperactivity on bee products

          -  positive anamnesis of anaphylactic reaction after bee bites

          -  skin wounds with skin surface discontinuation

          -  RDC/TMD 2 and 3
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Baron, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Medical University of Silesia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of TMD and Orthodontics Silesian Medical University</name>
      <address>
        <city>Zabrze</city>
        <zip>41-800</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Hellner M, Winter D, von Georgi R, Münstedt K. Apitherapy: usage and experience in german beekeepers. Evid Based Complement Alternat Med. 2008 Dec;5(4):475-9. doi: 10.1093/ecam/nem052. Epub 2007 Jun 30.</citation>
    <PMID>18955222</PMID>
  </reference>
  <reference>
    <citation>Więckiewicz W, Miernik M, Więckiewicz M, Morawiec T. Does propolis help to maintain oral health? Evid Based Complement Alternat Med. 2013;2013:351062. doi: 10.1155/2013/351062. Epub 2013 Jan 9.</citation>
    <PMID>23365605</PMID>
  </reference>
  <reference>
    <citation>Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, Beitz AJ, Lee JH. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002 May 31;71(2):191-204.</citation>
    <PMID>12031688</PMID>
  </reference>
  <reference>
    <citation>Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007 Aug;115(2):246-70. Epub 2007 May 6. Review.</citation>
    <PMID>17555825</PMID>
  </reference>
  <reference>
    <citation>Seo BK, Lee JH, Sung WS, Song EM, Jo DJ. Bee venom acupuncture for the treatment of chronic low back pain: study protocol for a randomized, double-blinded, sham-controlled trial. Trials. 2013 Jan 14;14:16. doi: 10.1186/1745-6215-14-16.</citation>
    <PMID>23317340</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2014</study_first_submitted>
  <study_first_submitted_qc>March 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2014</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Silesia</investigator_affiliation>
    <investigator_full_name>Aleksandra Nitecka-Buchta</investigator_full_name>
    <investigator_title>D.M.D.</investigator_title>
  </responsible_party>
  <keyword>TMD</keyword>
  <keyword>bee venom</keyword>
  <keyword>muscle tension</keyword>
  <keyword>muscle pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Petrolatum</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

